CXCR4 and prostate cancer: AR signaling was shown to activate CXCR4 protein expression through KLF5 in prostate cancer cells, propelling chemotactic migration in response to CXCL12, a chemokine abundantly present in the microenvironment and specific sites of metastasis [104,105].